Rezolute Inc (RZLT)
Rezolute stock today
Rezolute closed at $3.95 on October 30, 2026, down 4.13% on the day. Over the past year it returned -59.8% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $380 million.
| Period | RZLT | S&P 500 (SPY) |
|---|---|---|
| 1 month | -4.6% | -0.9% |
| 3 months | -19.1% | +2.1% |
| Year to date | +67.4% | +11.7% |
| 1 year | -59.8% | +12.4% |
| 3 years | +276.2% | +88.5% |
| 5 years | -38.3% | +76.0% |
Key statistics
- Market value
- $380M
- 52-week range
- $1.40 to $10.94
- Next report
- Nov 5, 2026 (estimated)
About Rezolute
Develops therapeutic drugs for metabolic and endocrine disorders.
Sector: Health Care
More on Rezolute
- Returns: what $1,000 became$1,000 ten years ago is $64.75 today
No forecast, no recommendation. This page describes Rezolute Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.